During the past decade, The First Affiliated Hospital of Xi'an Jiaotong University conducted 477 clinical trials. In the 10-year time frame, 477 clinical trials started and 38 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 290 clinical trials started and 29 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Xi'an Jiaotong University" #1 sponsor was "First Affiliated Hospital Xi'an Jiaotong University" with 161 trials, followed by "Hoffmann-La Roche" with 29 trials sponsored, "Eli Lilly and Company" with 16 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 15 trials sponsored and "Janssen Research & Development, LLC" with 15 trials sponsored. Other sponsors include 268 different institutions and companies that sponsored additional 148 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Xi'an Jiaotong University" #1 collaborator was "First Affiliated Hospital Xi'an Jiaotong University" with 24 trials as a collaborator, "Tang-Du Hospital" with 16 trials as a collaborator, "Shaanxi Provincial People's Hospital" with 14 trials as a collaborator, "General Hospital of Ningxia Medical University" with 11 trials as a collaborator and "Second Affiliated Hospital of Xi'an Jiaotong University" with 10 trials as a collaborator. Other collaborators include 886 different institutions and companies that were collaborators in the rest 497 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Xi'an Jiaotong University" are "Coronary Artery Disease" (10 trials), "Gastric Cancer" (9 trials), "Hepatitis B, Chronic" (9 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials) and "Hepatocellular Carcinoma" (8 trials). Many other conditions were trialed in "The First Affiliated Hospital of Xi'an Jiaotong University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Xi'an Jiaotong University" are "Drug" (299 trials), "Other" (68 trials), "Procedure" (57 trials), "Device" (53 trials) and "Biological" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (72 trials), "Pembrolizumab" (15 trials), "Cisplatin" (13 trials), "Paclitaxel" (12 trials) and "Capecitabine" (10 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Xi'an Jiaotong University" are 448 trials for "All" genders, 44 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 276 active trials in "The First Affiliated Hospital of Xi'an Jiaotong University". 23 are not yet recruiting, 173 are recruiting, 74 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 114 completed trials in The First Affiliated Hospital of Xi'an Jiaotong University, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Xi'an Jiaotong University, 27 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 162 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 128 trials that are defined as “Not Applicable".